Update
$VYNE Therapeutics (VYNE.US)$ VYNE Therapeutics Announces Positive Biomarker Data From Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
GlobeNewswire· 5 mins ago
GlobeNewswire· 5 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment